80 related articles for article (PubMed ID: 11486817)
1. Development of an enzyme immunoassay for a stable amidated analog of the hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro.
Junot C; Theodoro F; Thierry J; Clement G; Wdzieczak-Bakala J; Ezan E
J Immunoassay Immunochem; 2001; 22(1):15-31. PubMed ID: 11486817
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric quantification of AcSDKP-NH2 in human plasma and urine and comparison with an immunoassay.
Mesmin C; Cholet S; Blanchard A; Chambon Y; Azizi M; Ezan E
Rapid Commun Mass Spectrom; 2012 Jan; 26(2):163-72. PubMed ID: 22173804
[TBL] [Abstract][Full Text] [Related]
3. Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline.
Suzuki Y; Itoh H; Katagiri F; Sato F; Kawasaki K; Sato Y; Mimata H; Takeyama M
J Pept Sci; 2012 Apr; 18(4):276-81. PubMed ID: 22396066
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
Junot C; Nicolet L; Ezan E; Gonzales MF; Menard J; Azizi M
J Pharmacol Exp Ther; 1999 Dec; 291(3):982-7. PubMed ID: 10565814
[TBL] [Abstract][Full Text] [Related]
5. The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation.
Robinson S; Lenfant M; Wdzieczak-Bakala J; Riches A
Stem Cells; 1993 Sep; 11(5):422-7. PubMed ID: 8241953
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation.
Gaudron S; Grillon C; Thierry J; Riches A; Wierenga PK; Wdzieczak-Bakala J
Stem Cells; 1999; 17(2):100-6. PubMed ID: 10195570
[TBL] [Abstract][Full Text] [Related]
7. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.
Rousseau-Plasse A; Wdzieczak-Bakala J; Lenfant M; Ezan E; Genet R; Robinson S; Briscoe T; Melville J; Riches A
Exp Hematol; 1998 Oct; 26(11):1074-9. PubMed ID: 9766448
[TBL] [Abstract][Full Text] [Related]
8. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
9. Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin-I-converting enzyme N-active site.
Rousseau-Plasse A; Lenfant M; Potier P
Bioorg Med Chem; 1996 Jul; 4(7):1113-9. PubMed ID: 8831983
[TBL] [Abstract][Full Text] [Related]
10. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice.
Wdzieczak-Bakala J; Grillon C; Robinson S; Riches A; Carde P; Lenfant M
Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192
[TBL] [Abstract][Full Text] [Related]
11. The physiological role of the endogenous colony forming units-spleen (CFU-S) inhibitor acetyl-N-Ser-Asp-Lys-Pro (AcSDKP).
Frindel E; Monpezat JP
Leukemia; 1989 Oct; 3(10):753-4. PubMed ID: 2779291
[TBL] [Abstract][Full Text] [Related]
12. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation.
Thierry J; Grillon C; Gaudron S; Potier P; Riches A; Wdzieczak-Bakala J
J Pept Sci; 2001 May; 7(5):284-93. PubMed ID: 11428549
[TBL] [Abstract][Full Text] [Related]
14. Characterization of immunoreactive acetyl-Ser-Asp-Lys-Pro in human plasma and urine by liquid chromatography-electrospray mass spectrometry.
Junot C; Pruvost A; Créminon C; Grognet JM; Benech H; Ezan E
J Chromatogr B Biomed Sci Appl; 2001 Mar; 752(1):69-75. PubMed ID: 11254199
[TBL] [Abstract][Full Text] [Related]
15. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
Azizi M; Ménard J; Peyrard S; Lièvre M; Marre M; Chatellier G
Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017
[TBL] [Abstract][Full Text] [Related]
16. Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography.
Cheviron N; Rousseau-Plasse A; Lenfant M; Adeline MT; Potier P; Thierry J
Anal Biochem; 2000 Apr; 280(1):58-64. PubMed ID: 10805521
[TBL] [Abstract][Full Text] [Related]
17. Tetrapeptide AcSDKP induces postischemic neovascularization through monocyte chemoattractant protein-1 signaling.
Waeckel L; Bignon J; Liu JM; Markovits D; Ebrahimian TG; Vilar J; Mees B; Blanc-Brude O; Barateau V; Le Ricousse-Roussanne S; Duriez M; Tobelem G; Wdzieczak-Bakala J; Lévy BI; Silvestre JS
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):773-9. PubMed ID: 16410461
[TBL] [Abstract][Full Text] [Related]
18. Biological activities of tetrapeptide AcSDKP on hemopoietic cell binding to the stromal cell in vitro.
Aizawa S; Toyama K; Mori KJ; Frindel E
Exp Hematol; 1992 Aug; 20(7):896-9. PubMed ID: 1628708
[TBL] [Abstract][Full Text] [Related]
19. Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay.
Pradelles P; Frobert Y; Créminon C; Liozon E; Massé A; Frindel E
Biochem Biophys Res Commun; 1990 Aug; 170(3):986-93. PubMed ID: 2202303
[TBL] [Abstract][Full Text] [Related]
20. Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
Oliveira CR; Paredes-Gamero EJ; Barbosa CM; Nascimento FD; Batista EC; Reis FC; Martins AH; Ferreira AT; Carmona AK; Pesquero JB; Tersariol IL; Araújo RC; Bincoletto C
Chem Biol Interact; 2010 Mar; 184(3):388-95. PubMed ID: 20096676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
